Analysis of APL1β28, a Surrogate Marker for Alzheimer Aβ42, Indicates Altered Precision of γ-Cleavage in the Brains of Alzheimer Disease Patients

Publisher： Karger

E-ISSN： 1660-2862|7|1-3|42-45

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.7, Iss.1-3, 2010-02, pp. : 42-45

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Relative Ratio and Level of Amyloid-β 42 Surrogate in Cerebrospinal Fluid of Familial Alzheimer Disease Patients with Presenilin 1 Mutations

By  

Neurodegenerative Diseases, Vol. 13, Iss. 2-3, 2013-10 ,pp. : 166-170

Karger

Access to resources Recommend Favorite

Increased Cerebrospinal Fluid Aβ38/Aβ42 Ratio in Alzheimer Disease

By  

Neurodegenerative Diseases, Vol. 2, Iss. 5, 2006-02 ,pp. : 242-245

Karger

Access to resources Recommend Favorite

Conformationally Altered p53: A Putative Peripheral Marker for Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 5, Iss. 3-4, 2008-03 ,pp. : 209-211

Karger

Access to resources Recommend Favorite

Oligomerization Partially Explains the Lowering of Aβ42 in Alzheimer’s Disease Cerebrospinal Fluid

By  

Neurodegenerative Diseases, Vol. 6, Iss. 4, 2009-06 ,pp. : 139-147

Karger

Access to resources Recommend Favorite

A Study of Aβ Oligomers in the Temporal Cortex and Cerebellum of Patients with Neuropathologically Confirmed Alzheimer's Disease Compared to Aged Controls

By  

Neurodegenerative Diseases, Vol. 16, Iss. 5-6, 2016-07 ,pp. : 398-406

Karger

Access to resources Recommend Favorite